Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Childhood cancer cells drain immune system's batteries

  • Team advances therapy preventing addiction relapse by erasing drug-associated memories

  • Sequential voting in presidential primaries best system to winnow candidates

  • Cures for PTSD often remain elusive for war veterans

  • Mindfulness-based stress reduction therapy decreases PTSD symptom severity among veterans

  • Progress has been made in reducing rates of violence in US; overall numbers remain high

  • Emergency department intervention does not reduce heavy drinking or partner violence

  • Intervention to screen women for partner violence does not improve health outcomes

  • Stressing about your math test? Your problem-solving abilities might suffer

  • How new moms assess their partners' ability to parent

  •